GeoVax Assets Non Current from 2010 to 2024
| GOVX Stock | USD 1.54 0.01 0.65% |
Check GeoVax Labs financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among GeoVax main balance sheet or income statement drivers, such as Depreciation And Amortization of 70.5 K, Interest Expense of 48.6 K or Total Revenue of 0.0, as well as many exotic indicators such as Price To Sales Ratio of 144, Dividend Yield of 0.0 or PTB Ratio of 1.62. GeoVax financial statements analysis is a perfect complement when working with GeoVax Labs Valuation or Volatility modules.
GeoVax | Assets Non Current |
About GeoVax Labs Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include GeoVax Labs income statement, its balance sheet, and the statement of cash flows. GeoVax Labs investors use historical funamental indicators, such as GeoVax Labs's Assets Non Current, to determine how well the company is positioned to perform in the future. Although GeoVax Labs investors may use each financial statement separately, they are all related. The changes in GeoVax Labs's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on GeoVax Labs's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on GeoVax Labs Financial Statements. Understanding these patterns can help to make the right decision on long term investment in GeoVax Labs. Please read more on our technical analysis and fundamental analysis pages.
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. GeoVax Labs, Inc. was incorporated in 1988 and is based in Smyrna, Georgia. Geovax Labs operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 11 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards GeoVax Labs in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, GeoVax Labs' short interest history, or implied volatility extrapolated from GeoVax Labs options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of GeoVax Labs Correlation against competitors. For more information on how to buy GeoVax Stock please use our How to Invest in GeoVax Labs guide.You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Complementary Tools for GeoVax Stock analysis
When running GeoVax Labs' price analysis, check to measure GeoVax Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeoVax Labs is operating at the current time. Most of GeoVax Labs' value examination focuses on studying past and present price action to predict the probability of GeoVax Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeoVax Labs' price. Additionally, you may evaluate how the addition of GeoVax Labs to your portfolios can decrease your overall portfolio volatility.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |
Is GeoVax Labs' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GeoVax Labs. If investors know GeoVax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GeoVax Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (14.29) | Quarterly Revenue Growth (1.00) | Return On Assets (0.82) | Return On Equity (1.60) |
The market value of GeoVax Labs is measured differently than its book value, which is the value of GeoVax that is recorded on the company's balance sheet. Investors also form their own opinion of GeoVax Labs' value that differs from its market value or its book value, called intrinsic value, which is GeoVax Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GeoVax Labs' market value can be influenced by many factors that don't directly affect GeoVax Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GeoVax Labs' value and its price as these two are different measures arrived at by different means. Investors typically determine if GeoVax Labs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GeoVax Labs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.